← Eichor
Study identifier: NCT06336382 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Tau Biomarkers in Late-onset Psychosis (LOP)

Condition: Late Onset Schizophrenia · Delusional Disorder (Late Onset)  ·  Sponsor: Jeremy Koppel

PhaseN/A
Planned participants16
Who can joinAll sexes, 65 Years to 85 Years
Healthy volunteersNo

About this study

Hallucinations or delusions that occur for the first time in older people with no acute medical problems or mood symptoms may be related to impending dementia. This study aims to confirm this hypothesis using novel blood biomarkers and Positron Emission Tomography (PET) imaging tracers, as well as non-invasive testing.

This description comes directly from the study's public registry record.

Talk to the study team

Nichole Hoehn, MS  ·  516-562-3492  ·  nhoehn@northwell.edu

Erica Christen, MS  ·  516-562-3492  ·  EChriste@northwell.edu

Always discuss trial participation with your own doctor first.

Locations (1)

The Feinstein Institutes for Medical ResearchManhasset, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06336382